OpenLegislation

Regulation 3 Amendment of the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015

Original text. Later amendments are not shown.

(1)

The following amendments are made to Schedule 1 to the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015f1 (which specifies controlled drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies).

(2)

In paragraph 1(a)—

(a)

after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;

(b)

after “1,4-Butanediol” insert “Butonitazene”;

(c)

after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;

(d)

after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;

(e)

after “Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)” insert—

“Diphenidine

Ephenidine

Ethyleneoxynitazene”;

(f)

after “Etizolam” insert—

“Etodesnitazene (etazene)

Etonitazene”;

(g)

after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;

(h)

after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;

(i)

after “Methcathinone” insert “Methoxyphenidine”;

(j)

after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—

“Metodesnitazene (metazene)

Metonitazene”;

(k)

after “Propylphenidate” insert “Protonitazene”;

(l)

after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—

“N-Desethyl etonitazene

N-Desethylisotonitazene

N-Desethyl protonitazene”;

(m)

after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—

“N-Piperidinyl-etonitazene (etonitazepipne)

N-Pyrrolidino-etonitazene (etoniazepyne)

N-Pyrrolidino protonitazene”.

Annotations

Footnotes

f1

S.I. 2015/704, amended by S.I. 2017/632. There are other amending instruments, but none are relevant.